p53-driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation

Maria Emanuela Cuomo, Axel Knebel, Nick Morrice, Hugh Paterson, Philip Cohen, Sibylle Mittnacht

    Research output: Contribution to journalArticlepeer-review

    44 Citations (Scopus)


    Chromosome loss or gain is associated with a large number of solid cancers, providing genomic plasticity and thus adaptability to cancer cells(1,2). Numerical centrosome abnormalities arising from centrosome over-duplication or failed cytokinesis are a recognized cause of aneuploidy(3,4). In higher eukaryotic cells, the centrosome duplicates only once per cell cycle to ensure the formation of a bipolar mitotic spindle that orchestrates the balanced distribution of the sister chromatids to the respective daughter cells(5). Here we delineate the events that allow abnormal centrosome duplication, resulting in mitotic errors and incorrect chromosome segregation in cells with sustained cyclin-dependent kinase (CDK) activity. We have identified NPM1 as a substrate for CDK6 activated by the Kaposi's sarcoma herpesvirus (KSHV) D-type cyclin and shown that p53-driven apoptosis occurs downstream of NPM1 phosphorylation as a checkpoint mechanism that prevents accumulation of cells with supernumerary centrosomes. Our findings provide evidence that abnormal chromosome segregation in KSHV-infected cells is a direct consequence of NPM1 phosphorylation and predict that genomic instability is an inevitable consequence of latent KSHV infection.

    Original languageEnglish
    Pages (from-to)723-730
    Number of pages8
    JournalNature Cell Biology
    Issue number6
    Publication statusPublished - Jun 2008


    • CYCLIN
    • P53
    • CANCER
    • KINASE


    Dive into the research topics of 'p53-driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation'. Together they form a unique fingerprint.

    Cite this